The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Theodore E. Warkentin

Ted Warkentin

MD, Room 1-270B

Hamilton Regional Laboratory Medicine Program

E-mail:

[email]@mcmaster.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Ted Warkentin, MD, Room 1-270B, Hamilton Regional Laboratory Medicine Program, E-mail:. 2012
  • Department of Pathology and Molecular Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Canada. 2002 - 2012
  • Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, 237 Barton Street E., Hamilton, Canada. 2003 - 2008
  • McMaster University, the Henderson Research Centre, and the Hamilton Regional Laboratory Medicine Program, Hamilton, Canada. 2003

References

  1. The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome. Warkentin, T.E., Chakraborty, A.K., Sheppard, J.A., Griffin, D.K. Thromb. Haemost. (2012) [Pubmed]
  2. HITlights: A career perspective on heparin-induced thrombocytopenia. Warkentin, T.E. Am. J. Hematol. (2012) [Pubmed]
  3. How I diagnose and manage HIT. Warkentin, T.E. Hematology. Am. Soc. Hematol. Educ. Program (2011) [Pubmed]
  4. Agents for the treatment of heparin-induced thrombocytopenia. Warkentin, T.E. Hematol. Oncol. Clin. North Am. (2010) [Pubmed]
  5. Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization. Warkentin, T.E., Cook, R.J., Marder, V.J., Greinacher, A. J. Thromb. Haemost. (2010) [Pubmed]
  6. Fondaparinux: does it cause HIT? Can it treat HIT? Warkentin, T.E. Expert. Rev. Hematol (2010) [Pubmed]
  7. Non-necrotizing heparin-induced skin lesions and the 4T's score. Warkentin, T.E., Linkins, L.A. J. Thromb. Haemost. (2010) [Pubmed]
  8. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Warkentin, T.E., Greinacher, A. Expert. Opin. Drug. Saf (2009) [Pubmed]
  9. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Warkentin, T.E., Greinacher, A., Koster, A. Ann. Thorac. Surg. (2009) [Pubmed]
  10. Antiphospholipid and anti-PF4 antibodies: an association affecting anti-PF4/heparin assay analysis. Warkentin, T.E. J. Thromb. Haemost. (2009) [Pubmed]
  11. Studies of the immune response in heparin-induced thrombocytopenia. Warkentin, T.E., Sheppard, J.A., Moore, J.C., Cook, R.J., Kelton, J.G. Blood (2009) [Pubmed]
  12. The paradox of heparin-induced thrombocytopenia. Warkentin, T.E. J. Thromb. Haemost. (2009) [Pubmed]
  13. Immunoassays are not created equal. Warkentin, T.E., Linkins, L.A. J. Thromb. Haemost. (2009) [Pubmed]
  14. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Warkentin, T.E., Makris, M., Jay, R.M., Kelton, J.G. Am. J. Med. (2008) [Pubmed]
  15. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Warkentin, T.E., Greinacher, A., Koster, A., Lincoff, A.M. Chest (2008) [Pubmed]
  16. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. Warkentin, T.E., Sheppard, J.I., Moore, J.C., Sigouin, C.S., Kelton, J.G. J. Thromb. Haemost. (2008) [Pubmed]
  17. Bivalirudin. Warkentin, T.E., Greinacher, A., Koster, A. Thromb. Haemost. (2008) [Pubmed]
  18. Heparin-induced thrombocytopenia. Warkentin, T.E. Hematol. Oncol. Clin. North Am. (2007) [Pubmed]
  19. PF4-dependent immunoassays and inferential detection of HIT antibodies. Warkentin, T.E. J. Thromb. Haemost. (2007) [Pubmed]
  20. HIT: lessons learned. Warkentin, T.E. Pathophysiol. Haemost. Thromb. (2006) [Pubmed]
  21. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Warkentin, T.E., Sheppard, J.A., Sigouin, C.S., Kohlmann, T., Eichler, P., Greinacher, A. Blood (2006) [Pubmed]
  22. Think of HIT. Warkentin, T.E. Hematology. Am. Soc. Hematol. Educ. Program (2006) [Pubmed]
  23. New approaches to the diagnosis of heparin-induced thrombocytopenia. Warkentin, T.E. Chest (2005) [Pubmed]
  24. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Warkentin, T.E., Roberts, R.S., Hirsh, J., Kelton, J.G. Chest (2005) [Pubmed]
  25. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU. Warkentin, T.E., Cook, D.J. Crit. Care. Clin (2005) [Pubmed]
  26. Bivalirudin: a review. Warkentin, T.E., Koster, A. Expert. Opin. Pharmacother (2005) [Pubmed]
  27. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Warkentin, T.E., Cook, R.J., Marder, V.J., Sheppard, J.A., Moore, J.C., Eriksson, B.I., Greinacher, A., Kelton, J.G. Blood (2005) [Pubmed]
  28. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?. Warkentin, T.E., Sheppard, J.A., Moore, J.C., Moore, K.M., Sigouin, C.S., Kelton, J.G. J. Lab. Clin. Med. (2005) [Pubmed]
  29. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. Warkentin, T.E., Greinacher, A., Craven, S., Dewar, L., Sheppard, J.A., Ofosu, F.A. Thromb. Haemost. (2005) [Pubmed]
  30. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis. Warkentin, T.E., Whitlock, R.P., Teoh, K.H. Am. J. Hematol. (2004) [Pubmed]
  31. Bivalent direct thrombin inhibitors: hirudin and bivalirudin. Warkentin, T.E. Best. Pract. Res. Clin. Haematol (2004) [Pubmed]
  32. An overview of the heparin-induced thrombocytopenia syndrome. Warkentin, T.E. Semin. Thromb. Hemost. (2004) [Pubmed]
  33. Heparin-induced thrombocytopenia and vascular surgery. Warkentin, T.E. Acta Chir. Belg. (2004) [Pubmed]
  34. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Warkentin, T.E., Greinacher, A. Chest (2004) [Pubmed]
  35. Heparin-induced thrombocytopenia: diagnosis and management. Warkentin, T.E. Circulation (2004) [Pubmed]
  36. Heparin-induced thrombocytopenia: pathogenesis and management. Warkentin, T.E. Br. J. Haematol. (2003) [Pubmed]
  37. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Warkentin, T.E. Thromb. Res. (2003) [Pubmed]
  38. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Warkentin, T.E., Heddle, N.M. Curr. Hematol. Rep. (2003) [Pubmed]
  39. Heparin-induced thrombocytopenia and cardiac surgery. Warkentin, T.E., Greinacher, A. Ann. Thorac. Surg. (2003) [Pubmed]
  40. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Warkentin, T.E., Moore, J.C., Anand, S.S., Lonn, E.M., Morgan, D.G. Transfus. Med. Rev (2003) [Pubmed]
  41. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Warkentin, T.E., Roberts, R.S., Hirsh, J., Kelton, J.G. Arch. Intern. Med. (2003) [Pubmed]
  42. Heparin-induced thrombocytopenia and cardiac surgery. Warkentin, T.E., Greinacher, A. Ann. Thorac. Surg. (2003) [Pubmed]
  43. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Warkentin, T.E. Arch. Pathol. Lab. Med. (2002) [Pubmed]
 
WikiGenes - Universities